--double whammy for adreno users
--Ferriprox =Iron reducer, adreno side effect drug of choice?
--Ferriprox=zinc deficiency, covid19 vulnerable
Ferriprox,coated capsule oral iron treatment of choice for adreno users.
1. bad guys wanted to remove worldwide license and distribution from Apotex?
2. white hats took over,use it to infect w potent covid on adreno users?, Shermans still alive?
Replication of human immunodeficiency virus type 1 (HIV-1) can be influenced by iron. Hence, decreasing the availability of iron may inhibit HIV-1 replication. Deferoxamine and deferiprone,both examined
similar mode of action for the two viral proteins, suggesting that anti-viral strategy that targets the viral-induced membrane fusion step can be adopted from HIV-1 to SARS-CoV.
withdrawn due to "comments received from the research community"
Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120
There are few cases of children developing full blown Covid-19, but we believe they can be carriers . Children have lower levels of ferritin. Is this helping to prevent the inflammatory response and the cytokine storm?
intentional for intial high fatality rates to spread fear?
Q/Q+ 4d Grandmaster Chess - Coronavirus engineered to hit (and IDENTIFY/PROVE) adrenochrome users the hardest?
Too much Adrenochrome in the body (through drinking blood) can increase the [[[IRON]]] count in the BLOOD and can prove to be fatal.
Issued: May 23, 2006
Expires: June 28, 2021
DEC 2017 SHERMAN MURDERS
FEB 19 2019 SUN PHARMA FDA APPROVAL FERRIPROX
Can't find anything about this. I thought manufacturer was CHIESI. ??
19 Dec 2019Apotex completes the phase II TWICE trial in Iron overload in Canada, Greece, Italy and USA (NCT03802916) (EudraCT2018-004016-22)
Adrenochrome user friendly?
iron, the iron deposits in tissues such as the liver and heart and endocrine glands disrupting normal function. Excessive accumulation in the heart can lead to cardiac
failure and arrhythmias leading to death.
The first drug approved for iron chelation, Desferal
(deferoxamine), was approved for use in 1968. However, not all patients can tolerate deferoxamine because of side effects and difficulties with its administration
• Deferoxamine (Desferal®, Novartis) powder for Injection Solution
(NDA 16267) approved on April 1, 1968
• Deferasirox (Exjade®, Novartis) tablets (NDA 21882) approved on Nov 2, 2005
October 14, 2011
• Deferasirox (Jadenu®, Novartis Pharmaceuticals) film-coated tablets (NDA 206910) approved on March 30, 2015.
Decreased plasma zinc concentrations have been observed on FERRIPROX therapy. Monitor plasma
zinc, and supplement in the event of a deficiency
**Bad for covid infected adrenochrome users.
CGP 37391; CMX 001 - CorMedix; CP 020; CP 20; CRMD-001; Ferriprox; Ferriprox Oral Solution; Kelfer; L1
Kindly share so that the health authorities of each country can make their respective analysis of this information, prevent further deaths and redirect investments appropriately